-
Recent Posts
- Coronavirus today and the SCI community tomorrow
- Stroke Drug Boosts Stem Cell Therapy For Spinal Cord Injury In Rats
- An integrated in silico pipeline identifies a novel TF combination that promotes enhanced CST growth following injury
- Spike timing-dependent plasticity in the adult rat with chronic cervical spinal cord contusion
- Effect of PTEN antagonist peptide on the functional motor recovery in rat
- GDF10 promotes axonal regeneration and functional recovery: A novel gene therapy strategy for spinal cord injury
- GTX Medical and NeuroRecovery Technologies to merge
- Candidate Therapy From Quebec for Chronic SCI Being Developed in Parallel by Academics and Companies in Switzerland and the Netherlands
- Moving beyond the glial scar for spinal cord repair
- The Struggle to Make CNS Axons Regenerate: Why Has It Been so Difficult?
- The potential of electric field for promoting neurite guidance in spinal cord injury regeneration strategies
- Extraction and selective activation of muscle synergies through spinal stimulation for SCI
- Early limb unloading elicits long-term motor deficits involving motorneuron hyperexcitability associated with persistent alterations in glutamatergic synaptic plasticity in spinal cord injury
- The effects of a pro-angiogenic, RGD-functionalized, nanofiber composite biomaterial on mesenchymal stem cell-mediated repair of the injured spinal cord
- From wheelchair to walking after spinal cord injury
Follow on Twitter
My TweetsSpinal Cord Injury Research and Science at Facebook
Categories
Archives
Tag Archives: Stem Cells Inc
StemCells, Inc. Announces Termination of Phase II Pathway Study Following Review of Data
NEWARK, Calif., May 31, 2016 (GLOBE NEWSWIRE) — StemCells, Inc. (STEM) (the “Company”) today announced its decision to terminate the Company’s Phase II Pathway Study in spinal cord injury following an in-depth review of data from the study and after … Continue reading
Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, Stem Cell Research
Tagged Stem Cells Inc
Comments Off on StemCells, Inc. Announces Termination of Phase II Pathway Study Following Review of Data
Stem Cells Inc announces new CEO and chronic SCI focus going forward
StemCells, Inc. (NASDAQ:STEM), a world leader in the research and development of cell-based therapeutics for the treatment of central nervous system disorders, today announced that Dr. Ian Massey, its President and Chief Operating Officer, has been appointed by the Board … Continue reading
Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, spinal cord injury research, Stem Cell Research
Tagged Dr. Ian Massey, Stem Cells Inc
Comments Off on Stem Cells Inc announces new CEO and chronic SCI focus going forward
Positive Six-Month Results, With Gains in Both Strength and Motor Function, for the First Cohort in the Phase II Pathway Study
Positive Six-Month Results, With Gains in Both Strength and Motor Function, for the First Cohort in the Phase II Pathway Study NEWARK, Calif., Nov. 18, 2015 (GLOBE NEWSWIRE) — StemCells, Inc.(NASDAQ:STEM), a world leader in the research and development of … Continue reading
Alliance for Regenerative Medicine: Stem Cells 2014
Presented by: Teresa Leezer, CEO RhinoCyte, Inc. is a privately owned biopharmaceutical company focused on developing transformational technologies that will change the way neurodegenerative disorders are treated. Founded in 2005, the Company is advancing innovative treatment paradigms that leverage proprietary … Continue reading
Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, spinal cord injury research, Stem Cell Research
Tagged Alliance for Regenerative Medicine, Asterias Biotherapeutics, InVivo Therapeutics, RhinoCyte, Stem Cells Inc
Comments Off on Alliance for Regenerative Medicine: Stem Cells 2014
Stem Cells Inc. update at Alliance for Regenerative Medicine (ARM)
Martin McGlynn, President and CEO of Stem Cells Inc. gives an update on Investor Day in New York City. For spinal cord injury they plan to release data in the second quarter of 2014 and open 20-30 additional sites to … Continue reading
Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, Stem Cell Research
Tagged Alliance for Regenerative Medicine, Martin McGlynn, Stem Cells Inc
Comments Off on Stem Cells Inc. update at Alliance for Regenerative Medicine (ARM)
What the Community Wants to Know! Aileen Anderson PhD, Stephen Huhn MD and Dr Thomas Answer Questions about StemCells Inc.
These online video presentations from the W2W 2012 symposium are only made possible through your generous contributions to U2FP. Aileen Anderson PhD, Stephen Huhn MD, Dr. Jonathan Thomas answer questions about the StemCells Inc. human clinical trial in Zurich.
Posted in Advocacy, Chronic Spinal Cord Injury Research, Regenerative Medicine, Rehabilitation, spinal cord injury research, Stem Cell Research
Tagged advocacy, Aileen Anderson PhD, axon regeneration, chronic spinal cord injury, CIRM, clinical trials spinal cord injury, Dr. Jonathon Thomas, embryonic stem cells, motor function, neurite growth, paralysis, regeneration, spinal cord injury research, stem cell biology, stem cells, Stem Cells Inc, StemCells Inc, Stephen Huhn MD, U2FP, Unite 2 Fight Paralysis, Unite2FightParalysis, Working 2 Walk 2012
Comments Off on What the Community Wants to Know! Aileen Anderson PhD, Stephen Huhn MD and Dr Thomas Answer Questions about StemCells Inc.
Aileen Anderson, PhD. – Presents at Working 2 Walk 2012
These online video presentations from the W2W 2012 symposium are only made possible through your generous contributions to U2FP. Aileen Anderson, PhD. Associate Professor, Reeve-Irvine Research Center “Stem Cell Strategies for Spinal Cord Injury: Managing the Microenvironment” Dr. Anderson investigates … Continue reading
Posted in Advocacy, Chronic Spinal Cord Injury Research, Regenerative Medicine, spinal cord injury research, Stem Cell Research
Tagged axon regeneration, axons, chronic spinal cord injury, CIRM, clinical trials spinal cord injury, Dr. Aileen Anderson, FDA, locomotion, motor function, neurite growth, NIH, paralysis, regeneration, RIRC, stem cell biology, Stem Cells Inc, U2FP, Unite 2 Fight Paralysis, Working 2 Walk 2012
Comments Off on Aileen Anderson, PhD. – Presents at Working 2 Walk 2012
Stephen Huhn, MD. – Presents at Working 2 Walk 2012
These online video presentations from the W2W 2012 symposium are only made possible through your generous contributions to U2FP. Stephen Huhn, MD, FACS, FAAP, Vice President, Head of the CNS Program, Stem Cells, Inc. “Phase I/II Study of Human Neural … Continue reading
Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, spinal cord injury research, Stem Cell Research
Tagged axon regeneration, chronic spinal cord injury, clinical trials spinal cord injury, Dr. Stephen Huhn, embryonic stem cells, FDA, regeneration, spinal cord injury research, Stem Cells Inc, U2FP, Unite 2 Fight Paralysis, Working 2 Walk 2012
Comments Off on Stephen Huhn, MD. – Presents at Working 2 Walk 2012
Dr. Armin Curt: Update on the Stem Cells Inc. Clinical Trial
Dr. Armin Curt, Professor and Chairman, Spinal Cord Injury Center at the University of Zurich, and Medical Director of the Paraplegic Center at the Balgrist University Hostpital, discusses latest clinical research in the use of neural stem cells to treat … Continue reading
Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, spinal cord injury research
Tagged chronic spinal cord injury, clinical trials spinal cord injury, Dr Armin Curt, Stem Cells Inc
Comments Off on Dr. Armin Curt: Update on the Stem Cells Inc. Clinical Trial
Working 2 Walk 2012 Science and Advocacy Symposium video presentations from Unite 2 Fight Paralysis will debut online!
Unite 2 Fight Paralysis hosted the annual Working 2 Walk Science and Advocacy Symposium in Irvine California for 2012. If you share our mission and goals, please consider making a donation that will help us continue this desperately needed work. … Continue reading
Posted in Advocacy, Biomaterials, Chronic Spinal Cord Injury Research, Neuroscience Abstracts, Regenerative Medicine, Rehabilitation, spinal cord injury research, Stem Cell Research
Tagged academic researchers, advocacy, axon regeneration, Bob Yant, Case Western Reserve University, Chondroitinase ABC, chronic spinal cord injury, CIRM, clinical trials spinal cord injury, corticospinal tract, Damodar Thapa, Dennis Tesolat, Dr. Aileen Anderson, Dr. Hans Keirstead, Dr. Jerry Silver, Dr. Justin M. Brown, Dr. Leif Havton, Dr. Mark Tuszynski, Dr. Murray Blackmore, Dr. Os Steward, Dr. Ravi Bellamkonda, Dr. Stephen Huhn, Jonathon Thomas, motor function, PhD, PTEN, RIRC, Roman Reed, Spasticity, Stem Cells Inc, U2FP, Unite 2 Fight Paralysis, Working 2 Walk 2012
Comments Off on Working 2 Walk 2012 Science and Advocacy Symposium video presentations from Unite 2 Fight Paralysis will debut online!